Using symptom check-ins to improve care for head and neck or lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial looks at better ways to help people with head and neck or lung cancer manage symptoms during their treatment. It focuses on using simple questionnaires to keep track of how you feel, so your care team can support you better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have head and neck cancer or lung cancer
- You are about to start or have recently started infusion (intravenous) treatment
- You can read and understand English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two ways of using telephone check-ins to help people manage side effects and emotional distress while taking oral anti-cancer pills at home. If you are starting or recently started an oral anti-cancer drug, you may be able to join.
This study looks at how physical activity (movement during the day) and a clinician-rated “day-to-day function” score relate to overall survival in people with certain cancers. It may help doctors understand who benefits most from activity-focused care and better monitoring.
This trial tests a nurse-led program to help manage symptoms before they start, for people with head and neck cancer who are getting radiation therapy. The goal is to improve quality of life during treatment.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This trial tests whether using a web-based tool to track symptoms can help people with advanced lung cancer live longer and feel better. You would report symptoms regularly, and your care team would use that information to adjust your care.
This study collects patient feedback through questionnaires to see if it helps improve outcomes for people with advanced non-small-cell lung cancer starting chemo-immunotherapy. It may help your care team better understand how you are feeling.
Hear when a new Malignant Solid Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.